G721-0282
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


G721-0282
Description:
G721-0282 is an orally active CHI3L1 inhibitor. G721-0282 can reduce the expression of inflammatory proteins and cytokines. G721-0282 inhibits the activation of the NF-κB signaling pathway. G721-0282 inhibits neuroinflammation and reduces anxious behavior. G721-0282 significantly inhibits the proliferation of osteosarcoma (OS) cells by suppressing the STAT3 signaling pathway. G721-0282 induces OS cell apoptosis by upregulating pro-apoptotic protein levels and downregulating anti-apoptotic protein levels. G721-0282 can be used for researches on neuroinflammatory conditions and cancer[1][2].UNSPSC:
12352005Target:
Apoptosis; Bcl-2 Family; CDK; COX; ERK; Glycosidase; NF-κB; p38 MAPK; STAT; SurvivinRelated Pathways:
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; JAK/STAT Signaling; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; Stem Cell/WntApplications:
COVID-19-anti-virusField of Research:
Cancer; Inflammation/Immunology; Neurological DiseaseSmiles:
O=C1C2=C(C(CCCC)=CN=C2N(C)C(N1C)=O)SCC(NCC=C)=OMolecular Formula:
C18H24N4O3SMolecular Weight:
376.47References & Citations:
[1]Ham HJ, et al. G721-0282 Exerts Anxiolytic-Like Effects on Chronic Unpredictable Mild Stress in Mice Through Inhibition of Chitinase-3-Like 1-Mediated Neuroinflammation. Front Cell Neurosci. 2022 Mar 7;16:793835|[2]Park KR, et al. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway. Int J Biol Sci. 2020 Jan 1;16 (2) :330-341.Shipping Conditions:
Room temperatureScientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
Bcl-2; CDK4; CDK6; COX-2; ERK; NF-κB; p38 MAPK; STAT3CAS Number:
946378-12-7
